Madrigal Pharmaceuticals, Inc. (LON:0JXI)
London
· Delayed Price · Currency is GBP · Price in USD 286.61
+3.41 (1.20%)
At close: Jun 4, 2025
Madrigal Pharmaceuticals Revenue
Madrigal Pharmaceuticals had revenue of $137.25M USD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $317.38M. In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M.
Revenue (ttm)
$317.38M
Revenue Growth
n/a
P/S Ratio
18.59
Revenue / Employee
$601.10K
Employees
528
Market Cap
4.57B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| HSBC Holdings | 44.89B |
| Shell | 217.54B |
| Unilever | 50.25B |
| Rolls-Royce Holdings | 18.91B |
| British American Tobacco p.l.c. | 25.87B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |